Evidence map›Paper›PMID 30456339›Full record

ArticleJACC. Basic to translational science2018

Novel Mechanistic Roles for Ankyrin-G in Cardiac Remodeling and Heart Failure.

Michael A Makara, Jerry Curran, Ellen R Lubbers, Nathaniel P Murphy, Sean C Little, Hassan Musa, Sakima A Smith, Sathya D Unudurthi, Murugesan V S Rajaram, Paul M L Janssen and 4 more

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Giant ankyrin-G regulates cardiac function.The Journal of biological chemistry
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Michael A MakaraDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Jerry CurranDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Ellen R LubbersDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Nathaniel P MurphyDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Sean C LittleDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Hassan MusaDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Sakima A SmithDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Sathya D UnudurthiDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Murugesan V S RajaramDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Paul M L JanssenDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Penelope A BoydenDepartment of Pharmacology, Columbia University, New York, New York.
Elisa A BradleyDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Thomas J HundDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
Peter J MohlerDorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, Ohio.
The Ohio State University Wexner Medical Center · USColumbia University · USThe Ohio State University · US

Funding

Defining novel mechanisms for human arrhythmiaR35HL135754 · NHLBI · OHIO STATE UNIVERSITY · PI MOHLER, PETER J. · 2017 to 2023
$6.0M
Defining novel mechanisms for regulation of atrial INa and arrhythmiasR01HL134824 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY, MOHLER, PETER J. · 2017 to 2020
$3.0M
EHD proteins in cardiac membrane protein targeting and remodelingR01HL114383 · NHLBI · OHIO STATE UNIVERSITY · PI BOYDEN, PENELOPE ALTMAN, MOHLER, PETER J. · 2013 to 2016
$2.1M
Defining the Impact of E-Cigarettes on Cardiac PathophysiologyR01HL139348 · NHLBI · OHIO STATE UNIVERSITY · PI WOLD, LOREN EUGENE · 2017 to 2020
$1.9M
CaMKII-dependent regulation of cardiac excitabilityR01HL114893 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY · 2012 to 2016
$1.9M
Spectrin-based regulation of cardiac remodeling and heart failureR01HL135096 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY · 2017 to 2020
$1.6M
Defining New Pathways in Heart Failure and ArrhythmiaK08HL135437 · NHLBI · OHIO STATE UNIVERSITY · PI SMITH, SAKIMA AHMAD · 2017 to 2021
$749k
Defining the Role of Alpha II Spectrin in Cardiac Function and DiseaseF30HL137331 · NHLBI · OHIO STATE UNIVERSITY · PI LUBBERS, ELLEN · 2017 to 2020
$176k
Defining Novel Mechanisms underlying Human Arrhythmogenic CardiomyopathyF30HL137325 · NHLBI · OHIO STATE UNIVERSITY · PI MURPHY, NATHANIEL PATRICK · 2017 to 2020
$163k
NHLBI NIH HHS F30 HL137325NHLBI NIH HHS F30 HL137331NHLBI NIH HHS K08 HL135437NHLBI NIH HHS R01 HL114383NHLBI NIH HHS R01 HL114893NHLBI NIH HHS R01 HL134824NHLBI NIH HHS R01 HL135096NHLBI NIH HHS R01 HL139348NHLBI NIH HHS R35 HL135754
6 · The paper itself

Abstract

Ankyrin polypeptides are intracellular proteins responsible for targeting cardiac membrane proteins. Here, the authors demonstrate that ankyrin-G plays an unexpected role in normal compensatory physiological remodeling in response to myocardial stress and aging; the authors implicate disruption of ankyrin-G in human heart failure. Mechanistically, the authors illustrate that ankyrin-G serves as a key nodal protein required for cardiac myofilament integration with the intercalated disc. Their data define novel in vivo mechanistic roles for ankyrin-G, implicate ankyrin-G as necessary for compensatory cardiac physiological remodeling under stress, and implicate disruption of ankyrin-G in the development and progression of human heart failure.

Indexed as

AnkG, ankyrin-GankyrinarrhythmiacKO, cardiomyocyte-specific knockoutcytoskeletonDSP, desmoplakinECG, electrocardiogramheart failureHF, heart failureion channelLV, left ventricularNav1.5PBS, phosphate-buffered salinePKP2, plakophilin-2TAC, transverse aortic constrictionTUNEL, terminal deoxynucleotidyl transferase dUTP nick-end labelingWT, wild-type

Identifiers

PMID30456339
PMCPMC6234521
OpenAlexW2900943057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.